Search results
Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.
Andrew Conrad, PhD, is the Chief Executive Officer, Chairman and Founder of Verily where he oversees an integrated team of engineers, scientists, designers, ...
Andrew Conrad is a healthcare entrepreneur and investor who leads Verily, a subsidiary of Alphabet. He also serves on the board of Genalyte, a biotech company, and advises SandboxAQ, an edtech startup.
Dr. Conrad is the Head of Google Life Sciences and a member of the Precision Medicine Initiative Working Group of the Advisory Committee to the Director. He has a background in genetics, biotechnology, and healthcare innovation.
Jul 27, 2020 · Verily CEO Andrew Conrad told employees he wants to end rivalries with Google Health, and it could mean the divisions ramp up collaborative efforts.
Dec 21, 2021 · Verily CEO Andy Conrad is taking a longer-term, more strategic role at the Alphabet life sciences company and is promoting chief operating officer Stephen Gillett to president and COO.
Dec 22, 2021 · Gillett, who joined Verily as COO in 2020, will work with CEO Andy Conrad and other executives to grow the Alphabet offshoot. Conrad will focus on long-term strategy, business development and partnerships.
